Molecule intelOpportunity: Lower0Crowded market

Tramadol

148 brands · 92 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
24
Market saturation
100
Price room
100
Regulatory risk
50
148
brands
92
companies
Rs 205.42
median price
58
price points
13.04x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 74.1
MedianRs 205.42
Most expensiveRs 966.45
Spread13.04×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 13.04x across 58 trusted points (Rs 74.1-966.45). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Tramadol — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2026-06-03
33. Rapid Alert – SPURIOUS DRUG PRODUCTS (NOVIDAT 500MG Tablets and TONOFLEX-P Tablets)

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

92 canonical companies and 148 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 13.04x across 58 trusted points (Rs 74.1-966.45). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-06-03 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.